$254 Million is the total value of JGP Global Gestao de Recursos Ltda.'s 52 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 90.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRUSTput | $117,200,000 | – | 400,000 | +100.0% | 46.10% | – |
| MELI | Buy | MERCADOLIBRE INC | $22,856,000 | +49.6% | 37,360 | +24.1% | 8.99% | +59.2% |
| SMH | VANECK VECTORS SEMICONDUCTORput | $22,036,000 | +3.6% | 200,000 | 0.0% | 8.67% | +10.3% | |
| VALE | Buy | VALE SA-SP ADRadr | $18,707,000 | +5.7% | 1,391,874 | +2.7% | 7.36% | +12.5% |
| PAGS | New | PAGSEGURO DIGITAL LTD-CL A | $16,562,000 | – | 425,000 | +100.0% | 6.52% | – |
| AVP | New | AVON PRODUCTS INC | $10,476,000 | – | 2,700,000 | +100.0% | 4.12% | – |
| FB | New | FACEBOOK INC-CLASS A | $9,650,000 | – | 50,000 | +100.0% | 3.80% | – |
| OIBRC | Sell | OI SA-ADRadr | $6,401,000 | +4.9% | 3,184,559 | -1.8% | 2.52% | +11.7% |
| LINX | New | LINX SA - ADRadr | $5,835,000 | – | 639,810 | +100.0% | 2.30% | – |
| GGAL | New | GRUPO FINANCIERO GALICIA-ADRadr | $2,657,000 | – | 74,850 | +100.0% | 1.04% | – |
| UNH | Sell | UNITEDHEALTH GROUP INC | $1,484,000 | -7.8% | 6,082 | -6.6% | 0.58% | -1.8% |
| SGEN | Buy | SEATTLE GENETICS INC | $1,245,000 | +2.9% | 17,985 | +8.8% | 0.49% | +9.6% |
| INCY | Sell | INCYTE CORP | $1,188,000 | -9.9% | 13,986 | -8.7% | 0.47% | -4.1% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $1,168,000 | +380.7% | 2,226 | +422.5% | 0.46% | +410.0% |
| BDX | New | BECTON DICKINSON AND CO | $1,088,000 | – | 4,317 | +100.0% | 0.43% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $914,000 | +100.4% | 4,986 | +101.0% | 0.36% | +113.0% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $868,000 | – | 2,957 | +100.0% | 0.34% | – |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $855,000 | -7.5% | 6,524 | -4.6% | 0.34% | -1.8% |
| SYK | New | STRYKER CORP | $696,000 | – | 3,385 | +100.0% | 0.27% | – |
| PFE | New | PFIZER INC | $681,000 | – | 15,720 | +100.0% | 0.27% | – |
| ANTM | Buy | ANTHEM INC | $677,000 | +81.5% | 2,399 | +84.5% | 0.27% | +92.8% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $646,000 | -26.0% | 3,530 | -35.7% | 0.25% | -21.4% |
| BMA | New | BANCO MACRO SA-ADRadr | $542,000 | – | 7,439 | +100.0% | 0.21% | – |
| BGNE | Buy | BEIGENE LTD-ADRadr | $541,000 | +9.1% | 4,365 | +16.2% | 0.21% | +16.4% |
| DHR | New | DANAHER CORP | $521,000 | – | 3,644 | +100.0% | 0.20% | – |
| CI | Buy | CIGNA CORP | $509,000 | +0.6% | 3,229 | +2.6% | 0.20% | +7.0% |
| LOMA | New | LOMA NEGRA CIA IND-SPON ADRadr | $503,000 | – | 42,955 | +100.0% | 0.20% | – |
| A | New | AGILENT TECHNOLOGIES INC | $501,000 | – | 6,704 | +100.0% | 0.20% | – |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $473,000 | +91.5% | 17,697 | +92.3% | 0.19% | +104.4% |
| HCA | New | HCA HEALTHCARE INC | $449,000 | – | 3,320 | +100.0% | 0.18% | – |
| LLY | Buy | ELI LILLY & CO | $438,000 | +16.2% | 3,957 | +36.1% | 0.17% | +23.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $400,000 | -66.2% | 4,669 | -64.9% | 0.16% | -64.1% |
| AMRN | Buy | AMARIN CORP PLC -ADRadr | $396,000 | +72.9% | 20,425 | +85.3% | 0.16% | +83.5% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $365,000 | -61.3% | 2,399 | -69.7% | 0.14% | -58.7% |
| ARRY | New | ARRAY BIOPHARMA INC | $358,000 | – | 7,724 | +100.0% | 0.14% | – |
| ASND | New | ASCENDIS PHARMA A/S - ADRadr | $343,000 | – | 2,981 | +100.0% | 0.14% | – |
| MRK | Sell | MERCK & CO. INC. | $341,000 | -21.2% | 4,067 | -21.9% | 0.13% | -16.2% |
| CNC | Sell | CENTENE CORP | $327,000 | -33.0% | 6,244 | -32.1% | 0.13% | -28.3% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $311,000 | +24.9% | 993 | +63.9% | 0.12% | +32.6% |
| AZN | New | ASTRAZENECA PLC-SPONS ADRadr | $307,000 | – | 7,432 | +100.0% | 0.12% | – |
| HUM | Sell | HUMANA INC | $297,000 | -50.5% | 1,119 | -50.4% | 0.12% | -47.3% |
| HOLX | New | HOLOGIC INC | $285,000 | – | 5,941 | +100.0% | 0.11% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $267,000 | – | 938 | +100.0% | 0.10% | – |
| COO | New | COOPER COS INC/THE | $255,000 | – | 758 | +100.0% | 0.10% | – |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $248,000 | -14.2% | 2,934 | -10.5% | 0.10% | -8.4% |
| CELG | Sell | CELGENE CORP | $243,000 | -48.7% | 2,634 | -47.6% | 0.10% | -45.1% |
| ARGX | Sell | ARGENX SE - ADRadr | $243,000 | -15.0% | 1,713 | -25.1% | 0.10% | -9.4% |
| AMGN | New | AMGEN INC | $221,000 | – | 1,201 | +100.0% | 0.09% | – |
| TFX | New | TELEFLEX INC | $215,000 | – | 650 | +100.0% | 0.08% | – |
| ILMN | Sell | ILLUMINA INC | $214,000 | -78.6% | 580 | -82.0% | 0.08% | -77.3% |
| EXAS | Sell | EXACT SCIENCES CORP | $201,000 | -64.2% | 1,703 | -73.7% | 0.08% | -61.8% |
| OIBRQ | OI SA-ADRadr | $11,000 | 0.0% | 28,567 | 0.0% | 0.00% | 0.0% | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -21,871 | -100.0% | -0.01% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -13,880 | -100.0% | -0.02% | – |
| DBVT | Exit | DBV TECHNOLOGIES SA-SPON ADRadr | $0 | – | -10,935 | -100.0% | -0.03% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -10,088 | -100.0% | -0.05% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -13,691 | -100.0% | -0.06% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -1,651 | -100.0% | -0.08% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -25,742 | -100.0% | -0.08% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -945 | -100.0% | -0.08% | – |
| PRQR | Exit | PROQR THERAPEUTICS NV | $0 | – | -16,433 | -100.0% | -0.08% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -3,296 | -100.0% | -0.09% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -13,097 | -100.0% | -0.09% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -4,189 | -100.0% | -0.10% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -6,759 | -100.0% | -0.10% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -939 | -100.0% | -0.10% | – |
| NTRA | Exit | NATERA INC | $0 | – | -13,518 | -100.0% | -0.10% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -15,344 | -100.0% | -0.11% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -3,817 | -100.0% | -0.11% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -4,438 | -100.0% | -0.12% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -6,370 | -100.0% | -0.12% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -2,723 | -100.0% | -0.15% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -8,523 | -100.0% | -0.15% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -18,973 | -100.0% | -0.17% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -3,791 | -100.0% | -0.17% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -33,471 | -100.0% | -0.17% | – |
| GWPH | Exit | GW PHARMACEUTICALS -ADRadr | $0 | – | -2,730 | -100.0% | -0.17% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -2,439 | -100.0% | -0.17% | – |
| ABT | Exit | ABBOTT LABORATORIES | $0 | – | -6,384 | -100.0% | -0.19% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -13,561 | -100.0% | -0.19% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -11,599 | -100.0% | -0.20% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -3,618 | -100.0% | -0.21% | – |
| STNE | Exit | STONECO LTD-Acall | $0 | – | -30,000 | -100.0% | -0.46% | – |
| STNE | Exit | STONECO LTD-Aput | $0 | – | -200,000 | -100.0% | -3.04% | – |
| EWZ | Exit | ISHARES MSCI BRAZIL ETFcall | $0 | – | -350,000 | -100.0% | -5.30% | – |
| KHC | Exit | KRAFT HEINZ CO/THEput | $0 | – | -550,000 | -100.0% | -6.64% | – |
| EWZ | Exit | ISHARES MSCI BRAZIL ETFetp | $0 | – | -600,000 | -100.0% | -9.09% | – |
| EEM | Exit | ISHARES MSCI EMERGING MARKETcall | $0 | – | -800,000 | -100.0% | -12.69% | – |
| SPY | Exit | SPDR S&P 500 ETF TRUSTcall | $0 | – | -300,000 | -100.0% | -31.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-07-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BMRN | 30 | Q3 2023 | 2.8% |
| INCYTE CORP | 28 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 26 | Q3 2023 | 3.9% |
| LILLY ELI & CO | 26 | Q3 2023 | 1.3% |
| REGENERON PHARMACEUTICALS | 26 | Q3 2023 | 1.6% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2023 | 5.9% |
| ACADIA PHARMACEUTICALS INC | 24 | Q3 2023 | 0.7% |
| THERMO FISHER SCIENTIFIC INC | 21 | Q3 2023 | 4.7% |
| ABBVIE INC | 21 | Q3 2023 | 1.9% |
| HUMANA INC | 21 | Q3 2023 | 1.6% |
View JGP Global Gestao de Recursos Ltda.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-19 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-04 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-05 |
| SC 13G | 2022-02-11 |
| 13F-HR | 2022-02-03 |
View JGP Global Gestao de Recursos Ltda.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.